Is UnitedHealth Group Incorporated (UNH) the Best Medical Stock to Buy According to Billionaires?

MT HANNACH
8 Min Read
Disclosure: This website may contain affiliate links, which means I may earn a commission if you click on the link and make a purchase. I only recommend products or services that I personally use and believe will add value to my readers. Your support is appreciated!

We recently published a list of 10 best medical actions to buy according to billionaires. In this article, we are going to take a look at Where United Acrupted (NYSE:Oneh) opposes other best medical actions to buy according to billionaires.

Some experts consider that medical actions, health care and large pharmacies are immune to commercial carnage, making it a safe refuge in the midst of uncertainty caused by Trump prices. On April 8, the strategist for the health care sector of Mizuho Securities America Jared Holz appeared on CNBC’s “power lunch” to find out if speculation around the health sector being a safe refuge during market disorders are true. He also explained why health companies fail to obtain increased respect for investors, given that health care represents 20% of the American economy, which results in around 1 / 5th in the country’s entire national production.

Holz said the country’s main health and pharmaceutical care companies undoubtedly help fight health problems. However, when we examine their financial models and the way in which their activities are currently created, we have generic patent cliffs in the next 5 to 7 years at the company’s long -term corner of the company, as well as price concessions with IRA and some of the Biden administration has set up. We have also obtained a degradation of short -term prices, and between these two lies and other reverse. The models therefore never align themselves well enough for investors to have a lot of confidence, because commercial models do not lend themselves to long -term viability. These are the main reasons why the sector and stocks have been under pressure for so long.

Read also: 10 best medium biotechnology actions to buy And 12 best diagnostic actions to invest now.

Holz also considered that the care managed, in particular the names focused on the government, are somewhat safe because they are isolated from prices as American companies. In fact, the economic slowdown is in fact beneficial to them because they want less use and less patience through the system, this is how they generally beat figures. He said that managed care had a good day and that investors might think about having certain companies in the sector.

It is however a relative game, because there are several different variables at stake, and investors play essentially to a game of hoppes to try to switch from one zone to another, whether it is prices, prices of drugs or other public policies. He painted a similar table for stocks of medical devices more focused on the United States. These two sectors therefore present less risks compared to others, which makes them a little refuge.

Share This Article
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *